The biotech downward spiral continues

U.S. biotech shares extended their downward spiral as concerns about drug pricing continued to plague the sector.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.